Studies in both humans and experimental animals indicate that there is potential for full remyelination following CNS demyelination, but the factors that control the degree of myelin repair are unknown. In the Theiler's virus model of demyelination CNS remyelination can be promoted either by global immunosuppression or by selective immunoglobulin therapy. In this paper we discuss whether immunoglobulin-mediated remyelination is a characteristic of immune-mediated demyelination, or whether immunoglobulin-mediated remyelination also occurs in the toxic-traumatic model of lysolecithin-induced demyelination. Our data support the hypothesis that even in a non-primary immune model of demyelination, manipulating the immune system can be beneficial in myelin repair.
Blakemore WF (1973) Demyelination in the superior cerebellar peducle in the mouse induced by Cuprizone. J Neurol Sci20: 63 - 72.
2.
Yajima K., Suzuki K. (1979) Demyelination and remyelination in the rat central nervous system following ethidium bromide injection. Lab Invest41: 385-392.
3.
Hall SM (1972) The effect of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord. J Cell Sci13: 257-277.
4.
Raine CS, Traugott U. (1985) Remyelination in chronic relapsing experimental allergic encephalomyelitis and multiple sclerosis. In: The pathology of myelinated axon (Adachi M, Hirano A, Aronson SM, (eds). New York: Igaku-Shoin, 229 - 275.
5.
Herndon RM, Price DP, Weiner LP (1977) Regeneration of oligodendroglia during recovery from demyelinating disease. Science195: 693 - 694.
6.
Rodriguez M. , Lennon VA (1990) Immunoglobulins promote remyelination in the central nervous system. Ann Neurol27: 12 - 17.
7.
Prineas JW, Connell F. (1979) Remyelination in multiple sclerosis. Ann Neurol5: 22 - 31.
8.
Rodriguez M. , Sheithauer B. (1994) Ultrastructure of multiple sclerosis. Ultrastruct Pathol18: 3 - 13.
9.
Ghatak NR, Hirano A., Doron Y., Zimmerman HM (1973) Remyelination in multiple sclerosis with peripheral type myelin. Arch Neurol29: 262 - 267.
10.
Rodriguez M. , Lindsley MD (1992) Immunosuppression promotes CNS remyelination in chronic virus-induced demyelinating disease . Neurology42: 348 - 357.
11.
Rodriguez M. , Lennon VA, Benveniste EN, Merrill JE (1987) Remyelination by oligodendrocytes stimulated by antiserum to spinal cord. J Neuropath Exp Neurol46: 84-95.
12.
Van Engelen Bgm , et al. (1995) Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis. J Neurol Neurosurg Psychiatry57: 65-68.
13.
Miller DJ, Sanborn KS, Katzman JA, Rodriguez M. (1994) Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis. J Neurosci14: 6230-6238.
14.
Achiron A., et al. (1994) Intravenous immunoglobulin treatment of experimental T-cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion. J Clin Invest93: 600-605.
15.
Trotter JL, van der Veen RC (1991) Autoantibodies in multiple sclerosis. In: Handbook of multiple sclerosisCook SD , (ed.) New York: Marcel Dekker , 151 - 168.
16.
Grundke-Iqbal I., Bornstein MB (1980) Multiple sclerosis: serum gamma globulin and demyelination in organ culture. Neurology30: 749 - 754.
17.
Link H., Baikg S., Kostulas V., Olsson O., Olsson T. (1989) Immunoglobulin-secreting cells in the cerebrospinal fluid from patients with tension headache. J Neuroimmunol25: 1 - 6.
18.
Walsh MJ, Tourtelotte WW (1986) Temporal invariance and clonal uniformity of brain and CSF IgG, IgA, and IgM in multiple slerosis. J Exp Med163: 41 - 53.
19.
Rostrom B. (1981) Specificity of antibodies in oligoclonal bands in patients with multiple sclerosis and cerebrovascular disease. Acta Neurol Scand63: 1- 84.
20.
Matsiota P. , et al. (1988) Comparative study of natural autoantibodies in the serum and cerebrospinal fluid of normal individuals and patients with multiple sclerosis and other neurological diseases. Ann Immunol (Inst Pasteur139: 99 - 108.
21.
Raine CS, Moore Grw, Hintzen R., Traugott U. (1988) Induction of oligodendrocyte proliferation and remyelination after chronic demyelination. Lab Invest59: 467- 476.
22.
Grabar P. (1983) Autoantibodies and the physiological role of immunoglobulins . Immunol Today4: 337-340.
23.
Coutinho A. (1989) Beyond clonal selection and network. Immunol Review110: 63-87.
24.
Kerlero de Rosbo N., Honegger P., Lassmann H., Matthieu JM (1990) Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin oligodendrocyte glycoprotein. J Neurochem55: 583- 587.
Raine CS, Diaz M., Pakingan M., Bomstein MB (1978) Anti-serum induced dissociation of myelinogenesis in vitro: an ultrastructural study. Lab Invest38: 397 - 403.
27.
Bansal R., Gard AL, Pfeiffer SE (1988) Stimulation of oligodendrocyte differentiation in culture by growth in the presence of a monoclonal antibody to sulfated glycolipid. J Neurosci Res21: 260 - 267.
28.
Rodriguez M. (1991) Immunoglobulins stimulate central nervous system remyelination: electron microscopic and morphometric analysis of proliferating cells. Lab Invest64: 358 - 370.
29.
Berneman A. , Ternynck T., Avramas S. (1992) Natural mouse IgG reacts with self antigens including molecules involved in the immune response. Eur J Immunol22: 625-633.
30.
van Engelen Bgm , et al. (1992) Improved vision after intravenous immunoglobulin in stable demyelinating optic neuritis. Ann Neurol32: 835-836.
31.
Blakemore WF (1973) Remyelination of the superior cerebellar peduncle in the mouse following demyelination induced by feeding Cuprizone. J Neurol Sci20: 73- 83.
32.
Ludwin SK (1988) Remyelination in the central nervous system and the peripheral nervous system. Adv Neurol47: 215-254.
33.
Moll C., Mourre C., Lazdunski M., Ulrich J. (1991) Increase of sodium channels in demyelinated lesions of multiple sclerosis. Brain Res556: 311- 316.
34.
Casteels-Van Daele M., Wijndale L., Hunninck K. (1990) Intravenous immune globulin and acute aseptic meningitis. N Engl J Med323: 614 - 615.
35.
Eeg-Olofsson O., Link H., Wigertz A. (1981) Concentrations of CSF proteins as a measure of blood brain barrier function and synthesis of IgG within the CSN in 'normal' subjects from the age of 6 months to 30 years. Acta Pediatr Scand70: 167-170.
36.
Cutler Rwp , Watters GW, Hammerstad JP, Merler E. (1967) Origin of cerebrospinal fluid gammaglobulin in subacute sclerosing leukoencephalitis . Arch Neurol17: 620-628.
37.
Frick E., Scheid-Seydel L. (1958) Untersuchungen mit J131-markiertem gamma-globulin zur Frage der Abstammung der Liquoreiweisskoerper. Klin Wochenschr36: 857-863.
38.
Tourtelotte WW, et al. (1980) Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate. Neurology30: 240 - 244.
39.
Miller DJ, Rodriguez M. (1995) A monoclonal antibody that promotes central nervous system remyelination in a model of multiple sclerosis is a natural autoantibody encoded by germline immunoglobulin genes. J Immunol154: 2640 - 2649.
